 "NTAGI analyses data of breakthrough infections to decide on booster dose")
To make a decision regarding a booster dose of the COVID-19 vaccine, the National Technical Advisory Group on Immunisation (NTAGI) is analyzing data of COVID-19 breakthrough infections in India, said sources on Tuesday.
As per the sources, "NTAGI is analyzing data of COVID-19 breakthrough infections in India, to look at the vaccine effectiveness and take a decision regarding additional and booster dose."
During its last meeting, the NTAGI had made no final recommendation on additional COVID-19 vaccine doses and vaccines for children. However, both the issues were discussed in the meeting and the booster dose was not on the agenda of today's meeting.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app